Clinical Trials Logo

Rectosigmoid Cancer clinical trials

View clinical trials related to Rectosigmoid Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT06435975 Completed - Rectal Cancer Clinical Trials

Physical Activity in Rectal Cancer Survivors

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test a telehealth-based personalized physical activity intervention in adult patients diagnosed with Stage I-III rectal cancer. The main question it aims to answer are how to better understand the experiences of rectal cancer survivors who are coping with bowel dysfunction and how physical activity can improve their quality of life. Participants will be asked to: 1. Complete surveys to assess bowel function and quality of life 2. Participate in 12 Telehealth Sessions (one session a week) to discuss and review bowel dysfunction 3. Perform daily physical activity

NCT ID: NCT05797064 Not yet recruiting - Surgery Clinical Trials

Establishment of a Feasibility Model for NOSE Surgery Based on Machine Learning

Start date: June 1, 2023
Phase:
Study type: Observational

The goal of this observational study is to test in patients with resectable rectosigmoid cancers. The main question it aims to answer is establishment of a feasibility model for predicting natural orifice specimen extraction surgery (NOSES) based on machine learning.

NCT ID: NCT05566249 Recruiting - Rectal Cancer Clinical Trials

A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

Start date: October 1, 2022
Phase:
Study type: Observational

This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.

NCT ID: NCT03043729 Completed - Rectal Cancer Clinical Trials

mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer

Start date: March 6, 2017
Phase: Phase 2
Study type: Interventional

Patients with locally advanced rectal or rectosigmoid cancer staged cT3 CRM-negative with MRI will receive 6 cycles of neoadjuvant treatment with mFOLFOX6 (Arm A) vs. mFOLFOX6 + aflibercept (Arm B) followed by surgery.

NCT ID: NCT02205307 Terminated - Rectal Cancer Clinical Trials

A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection

PILLAR III
Start date: January 2015
Phase: N/A
Study type: Interventional

This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection procedures where colon and rectal tissue perfusion is evaluated using PINPOINT as an adjunct to standard surgical practice compared to surgical procedures performed according to standard surgical practice alone.